- Industry Left Col
- Industry Right Col
Turn Asset Management to Competitive Advantage
Today you know when your critical assets and facilities are up and running, and when they’re available, and can assume all is fine. But how close are you to your next service or a failure? How much will it cost? What if you could remove the risk? What if you never had to worry about the status of your assets and facilities again? In order to mitigate the above, what if you could turn asset management to competitive advantage? This webinar, showcasing technology developed by HCL and Infor will cover topics such as:
- Competitive bidding for contracts
- Managing margins and profitability
- Continual monitoring of asset / facilities performance
- Regulatory compliance and industry regulations
You’ll also get a look at HCL’s custom-built Construction extensions for LN CloudSuite. From project estimation, project preparation, project execution and project closure, HCL will walk-through some of their solutions for Bill of Quantities (BOQ), Construction Industry Scheme (CIS), Cost Variance Report (CVR), Snagging and BIM.
HCL understands the unique Construction industry value chain and provides solutions that allow for a higher-than-ever degree of collaboration and data-driven decision-making to optimize costs and maximize organizational effectiveness and operational efficiency. HCL is a renowned name in the niche area of business benefits-led programs with the ability to offer committed year-on-year productivity on not just IT SLAs and KPIs but also on the key indicators that drive construction companies.
About the speakers
EAM Industries Solution Consultant (Infor)
Jian Low is based in the United Kingdom. He has 9 years of experience in Enterprise Asset Management (EAM) and Operations Management (OM), with a focus across various industries.
Head of Infor Sales & Alliances EMEA, HCL Technologies
Professional with vast experience of 33 years in IT, across a diverse range of industries including Construction (Housing & Civil), Rail, Manufacturing, and Pharma.